Nystatin: Difference between revisions
| Line 9: | Line 9: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Oral Candidiasis: | |||
**4-6 mL PO QID of 100,000U/mL until 48 hrs after symptoms resolve | |||
*Intestinal candidiasis | |||
**1-2 tabs (500,000 U) PO TID until 48 hrs after symptoms resolve | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 23:17, 14 September 2015
Administration
- Type: Antifungal
- Dosage Forms:
- Routes of Administration:
- PO
- Topical
- Vaginal
- Common Trade Names: Nystop, Nyamyc
Adult Dosing
- Oral Candidiasis:
- 4-6 mL PO QID of 100,000U/mL until 48 hrs after symptoms resolve
- Intestinal candidiasis
- 1-2 tabs (500,000 U) PO TID until 48 hrs after symptoms resolve
Pediatric Dosing
Special Populations
- Pregnancy Rating: C
- Lactation risk: Safe
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hypersensitivity rxn
Common
- Nausea / Vomiting
- Diarrhea
- Abdominal Pain
Pharmacology
- Half-life: unknown
- Metabolism: CYP450
- Excretion: Feces
Mechanism of Action
Comments
See Also
References
- Epocrates 2015